SCHEMBL10712349

SCHEMBL10712349

Nc1ncnc2c1ncn2[C@@H]1O[C@H](COCC(c2ccccc2)c2ccc(F)cc2)[C@@H](O)[C@H]1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.62
P2RY1 P47900 4/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
P2RY2 P41231 3/20 0.58
SRC P12931 2/20 0.58
DNPH1 O43598 1/20 0.58
PRKAB2 O43741 1/20 0.58
TRPM2 O94759 1/20 0.58
LDHA P00338 1/20 0.58
ADRB2 P07550 1/20 0.58
FBP1 P09467 1/20 0.58
PRKAG1 P54619 1/20 0.58
PRKAA2 P54646 1/20 0.58
PDE4D Q08499 1/20 0.58
KCNH2 Q12809 1/20 0.58
PRKAA1 Q13131 1/20 0.58
PDE3A Q14432 1/20 0.58
TAS1R3 Q7RTX0 1/20 0.58
TAS1R1 Q7RTX1 1/20 0.58
P2RY11 Q96G91 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11016803 0.97 ADORA1 (0.60) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL3450680 0.95 ADORA1 (0.68) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL10711088 0.91 ADORA1 (0.62) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL10709093 0.90 ADORA1 (0.62) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL2519178 0.89 ADORA1 (0.66) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL10708260 0.89 HINT1 (0.61) ADORA1ADORA3ADORA2AADORA2B
SCHEMBL10707536 0.88 ADORA1 (0.60) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL7793910 0.88 ADORA1 (0.66) ADORA1P2RY1SMN1; SMN2P2RY2SRC
SCHEMBL10710913 0.87 ADORA3 (0.66) ADORA1P2RY1P2RY11ADORA3ADORA2A
SCHEMBL10709852 0.87 ADORA1 (0.59) ADORA1P2RY1SMN1; SMN2P2RY2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0139358-B1 N6-SUBSTITUTED DIARYLALKYL ADENOSINES, PROCESSES FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME WARNER-LAMBERT COMPANY (US) 1988-11-09 EP disclosed
EP-0139358-A2 N6-substituted diarylalkyl adenosines, processes for their production and pharmaceutical compositions comprising the same WARNER-LAMBERT COMPANY (US) 1985-05-02 EP disclosed